Medium materiality5/10
H.C. Wainwright initiates Parabilis Medicines at Buy
Why it may matterVerify against the original reporting
Bullish analyst initiation with substantial stated upside, tempered by the uncertainty of a single analyst target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright initiated coverage with a Buy rating and a $40 target, about 44% above the posted price of $27.85. This is an analyst view, not a guarantee of upside.
- Buy initiation; $40 target versus $27.85 posted price.
Key facts
- 01
Target: $40
- 02
Posted price: $27.85
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Robert Burns
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.